GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jun 4, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on June 4, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share transactions, not indicating new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker executing share purchases
- June 4, 2025 (date) — Date of announcement and transaction
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing reports on GSK plc's transactions in its own shares.
Who is acting as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker.
On what date did GSK announce these share transactions?
GSK announced these share transactions on June 4, 2025.
Does the filing specify the number of shares purchased?
No, the filing states that GSK has purchased 'the following number of the Company's ordinary shares' but does not specify the exact quantity in the provided text.
What is the par value of GSK's ordinary shares mentioned in the filing?
The ordinary shares are of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 4, 2025 regarding GSK plc (GLAXF).